期刊文献+

认知能力可预测轻至中度痴呆的治疗决策能力 被引量:1

Cognitive performance predicts treatment decisional abilities in mild to moderate dementia
下载PDF
导出
摘要 Objective: To examine the contribution of neuropsychological test performance to treatment decision-making capacity in community volunteers with mild to moderate dementia. Methods: The authors recruited volunteers (44 men, 44 women) with mild to moderate dementia from the community. Subjects completed a battery of 11 neuropsychological tests that assessed auditory and visual attention, logical memory, language, and executive function. To measure decision making capacity, the authors administered the Capacity to Consent to Treatment Interview, the Hopemont Capacity Assessment Interview, and the MacCarthur Competence Assessment Tool-Treatment. Each of these instruments individually scores four decisional abilities serving capacity: understanding, appreciation, reasoning, and expression of choice. The authors used principal components analysis to generate component scores for each ability across instruments, and to extract principal components for neuropsychological performance. Results: Multiple linear regression analyses demonstrated that neuropsychological performance significantly predicted all four abilities. Specifically, it predicted 77.8%of the common variance for understanding, 39.4%for reasoning, 24.6%for appreciation, and 10.2%for expression of choice. Except for reasoning and appreciation, neuropsychological predictor (β)profiles were unique for each ability. Conclusions: Neuropsychological performance substantially and differentially predicted capacity for treatment decisions in individuals with mild to moderate dementia. Relationships between elemental cognitive function and decisional capacity may differ in individuals whose decisional capacity is impaired by other disorders, such as mental illness. Objective: To examine the contribution of neuropsychological test performance to treatment decision-making capacity in community volunteers with mild to moderate dementia. Methods: The authors recruited volunteers (44 men, 44 women) with mild to moderate dementia from the community. Subjects completed a battery of 11 neuropsychological tests that assessed auditory and visual attention, logical memory, language, and executive function. To measure decision making capacity, the authors administered the Capacity to Consent to Treatment Interview, the Hopemont Capacity Assessment Interview, and the MacCarthur Competence Assessment Tool-Treatment. Each of these instruments individually scores four decisional abilities serving capacity: understanding, appreciation, reasoning, and expression of choice. The authors used principal components analysis to generate component scores for each ability across instruments, and to extract principal components for neuropsychological performance. Results: Multiple linear regression analyses demonstrated that neuropsychological performance significantly predicted all four abilities. Specifically, it predicted 77.8% of the common variance for understanding, 39.4% for reasoning, 24.6% for appreciation, and 10.2% for expression of choice. Except for reasoning and appreciation, neuropsychological predictor (β)profiles were unique for each ability. Conclusions: Neuropsychological performance substantially and differentially predicted capacity for treatment decisions in individuals with mild to moderate dementia.
出处 《世界核心医学期刊文摘(神经病学分册)》 2006年第9期25-25,共1页 Digest of the World Core Medical Journals:Clinical Neurology
  • 相关文献

同被引文献40

  • 1潘忠德,谢斌,郑瞻培.精神障碍者知情同意能力的评定[J].上海精神医学,2003,15(6):376-378. 被引量:7
  • 2潘忠德,谢斌,卞茜,沈文龙,蔡伟雄.精神障碍者知情同意能力评估问卷的编制[J].上海精神医学,2005,17(1):29-32. 被引量:8
  • 3潘忠德,谢斌,卞茜,沈文龙,蔡伟雄.精神障碍者知情同意能力评估问卷的临床应用[J].上海精神医学,2005,17(2):69-71. 被引量:8
  • 4Appelbaum PS,Grisso T.The Mac Arthur treatment competence study.Ⅰ:mental illness and competence to consent to treatment[J].LawHuman Behav,1995,19(2):105-126.
  • 5Hales RE,Yudofsky SC,Gabbard GO.Textbook of psychiatry[M].5th Ed.Arlington:American Psychiatric Publishing,Inc.2008:1601-1637.
  • 6第十一届全国人民代表大会常务委员会第二十九次会议.中华人民共和国精神卫生法[M].北京:中国法制出版社,2012.
  • 7Dunn LB,Jeste DV.Enhancing informed consent for research and treatment[J].Neuropsychopharmacology,2001,24(6):595-607.
  • 8Applebaum PS.Consent in impaired populations[J].Curr Neurol Neurosci Rep,2010,10(5):367-373.
  • 9Palmer BW,Dunn LB,Appelbaum PS,et al.Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia[J].Arch Gen Psychiatry,2004,61(3):230-236.
  • 10Moye J,Gurrera RJ,Karel MJ,et al.Empirical advances in the assessment of the capacity to consent to medical treatment:clinical implications and research needs[J].Clin Psychol Rev,2006,26(8):1054-1077.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部